OX40 ligation on activated T cells enhances the control of Cryptococcus neoformans and reduces pulmonary eosinophilia

J Immunol. 2003 Jun 15;170(12):6125-32. doi: 10.4049/jimmunol.170.12.6125.

Abstract

Pulmonary eosinophilia induced in C57BL/6 mice after Cryptococcus neoformans infection is driven by CD4(+) Th2 cells. The immunological mechanisms that protect against eosinophilia are not fully understood. Interaction of OX40 (CD134) and its ligand, OX40L, has been implicated in T cell activation and cell migration. Unlike CD28, OX40 is only expressed on T cells 1-2 days after Ag activation. Manipulation of this pathway would therefore target recently activated T cells, leaving the naive repertoire unaffected. In this study, we show that engagement of OX40 by an OX40L:Ig fusion protein drives IFN-gamma production by CD4(+) T cells and reduces eosinophilia and C. neoformans burden in the lung. Using gene-depleted mice, we show that reduction of eosinophilia and pathogen burden requires IL-12 and/or IFN-gamma. C. neoformans infection itself only partially induces OX40L expression by APCs. Provision of exogenous OX40L reveals a critical role of this pathway in the prevention of C. neoformans-induced eosinophilia.

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / biosynthesis
  • Adjuvants, Immunologic / metabolism*
  • Adjuvants, Immunologic / physiology
  • Animals
  • Antigens, Differentiation / administration & dosage
  • Antigens, Differentiation / metabolism
  • Bronchi / immunology
  • Bronchi / metabolism
  • Bronchi / microbiology
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / metabolism
  • CD4-Positive T-Lymphocytes / microbiology
  • Cryptococcus neoformans / growth & development
  • Cryptococcus neoformans / immunology*
  • Down-Regulation / immunology*
  • Eosinophils / immunology
  • Eosinophils / pathology
  • Female
  • Injections, Intraperitoneal
  • Interferon-gamma / biosynthesis
  • Interferon-gamma / deficiency
  • Interferon-gamma / genetics
  • Interferon-gamma / physiology
  • Ligands
  • Lung / immunology
  • Lung / metabolism
  • Lung / microbiology
  • Lymphocyte Activation / immunology*
  • Membrane Glycoproteins / administration & dosage
  • Membrane Glycoproteins / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • OX40 Ligand
  • Pulmonary Eosinophilia / genetics
  • Pulmonary Eosinophilia / microbiology
  • Pulmonary Eosinophilia / pathology
  • Pulmonary Eosinophilia / prevention & control*
  • Receptors, OX40
  • Receptors, Tumor Necrosis Factor*
  • Recombinant Fusion Proteins / administration & dosage
  • Recombinant Fusion Proteins / metabolism
  • T-Lymphocyte Subsets / immunology*
  • T-Lymphocyte Subsets / metabolism
  • T-Lymphocyte Subsets / microbiology*
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / administration & dosage
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / biosynthesis
  • Tumor Necrosis Factor Receptor Superfamily, Member 7 / metabolism*
  • Tumor Necrosis Factors

Substances

  • Adjuvants, Immunologic
  • Antigens, Differentiation
  • Ligands
  • Membrane Glycoproteins
  • OX40 Ligand
  • OX40Ig
  • Receptors, OX40
  • Receptors, Tumor Necrosis Factor
  • Recombinant Fusion Proteins
  • Tnfrsf4 protein, mouse
  • Tnfsf4 protein, mouse
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • Tumor Necrosis Factors
  • Interferon-gamma